698 related articles for article (PubMed ID: 19077110)
21. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
Watson GS; Craft S
J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and the degenerative diseases of aging.
McGeer PL; McGeer EG
Ann N Y Acad Sci; 2004 Dec; 1035():104-16. PubMed ID: 15681803
[TBL] [Abstract][Full Text] [Related]
23. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
McQuaid S; Cunnea P; McMahon J; Fitzgerald U
Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
[TBL] [Abstract][Full Text] [Related]
24. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
Lagodka A; Robert P
Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
[TBL] [Abstract][Full Text] [Related]
25. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
Sindic CJ
Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
[TBL] [Abstract][Full Text] [Related]
26. [Long-term cerebral effects of perinatal inflammation].
Chhor V; Schang AL; Favrais G; Fleiss B; Gressens P
Arch Pediatr; 2012 Sep; 19(9):946-52. PubMed ID: 22885003
[TBL] [Abstract][Full Text] [Related]
27. The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Doty RL
Ann Neurol; 2008 Jan; 63(1):7-15. PubMed ID: 18232016
[TBL] [Abstract][Full Text] [Related]
28. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
29. Humoral immunity in brain aging and Alzheimer's disease.
Bouras C; Riederer BM; Kövari E; Hof PR; Giannakopoulos P
Brain Res Brain Res Rev; 2005 Jun; 48(3):477-87. PubMed ID: 15914253
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
31. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
Modi G; Pillay V; Choonara YE
Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
[TBL] [Abstract][Full Text] [Related]
32. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
Grammas P; Martinez J; Miller B
Expert Rev Mol Med; 2011 Jun; 13():e19. PubMed ID: 21676288
[TBL] [Abstract][Full Text] [Related]
33. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
[TBL] [Abstract][Full Text] [Related]
34. The contribution of the study of neurodegenerative disorders to the understanding of human memory.
Panegyres PK
QJM; 2004 Sep; 97(9):555-67. PubMed ID: 15317924
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier changes in multiple sclerosis.
Trojano M; Manzari C; Livrea P
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
[TBL] [Abstract][Full Text] [Related]
37. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress.
Lau FC; Shukitt-Hale B; Joseph JA
Subcell Biochem; 2007; 42():299-318. PubMed ID: 17612057
[TBL] [Abstract][Full Text] [Related]
38. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
Marchetti B; Abbracchio MP
Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
[TBL] [Abstract][Full Text] [Related]
39. Synapse elimination during development and disease: immune molecules take centre stage.
Schafer DP; Stevens B
Biochem Soc Trans; 2010 Apr; 38(2):476-81. PubMed ID: 20298206
[TBL] [Abstract][Full Text] [Related]
40. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease.
Jeynes B; Provias J
J Neurosci Res; 2011 Jan; 89(1):22-8. PubMed ID: 21046564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
